Equity Overview
Price & Market Data
Price: $3.92
Daily Change: $0.00 / 0.00%
Daily Range: $3.41 - $4.78
Market Cap: $17,634,940
Daily Volume: 9,845,178
Performance Metrics
1 Week: -17.30%
1 Month: 280.6%
3 Months: 232.2%
6 Months: 35.17%
1 Year: -85.32%
YTD: 232.2%
Company Details
Employees: 57
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.